Deep vein thrombosis
387 results
201 - 300
Surgery for deep venous insufficiency- Interrupted versus uninterrupted anticoagulation for cardiac rhythm management device insertion
- Topical application of tranexamic acid for the reduction of bleeding
Compression therapy for prevention of post-thrombotic syndrome - Interventions for preventing venous thromboembolism in adults undergoing knee arthroscopy
- Dabigatran versus LMWHs for thromboprophylaxis after total hip or knee replacement
Obesity not associated with adverse hip replacement outcomes- Effect of testing for cancer on cancer‐ or venous thromboembolism (VTE)‐related mortality and morbidity in people with unprovoked VTE
- Pulmonary embolism
- Lower leg fractures
- Updated American College of Chest Physicians guideline on antithrombotic therapy for venous thromboembolism
- Semuloparin reduces VTE in cancer patients but at high cost (SAVE-ONCO)
- Idarucizumab can reverse anticoagulation of dabigatran
- Interventions for varicose veins and leg oedema in pregnancy
- Primary prophylaxis for venous thromboembolism in patients undergoing cardiac or thoracic surgery
- Sclerotherapy for varicose veins
- Injection sclerotherapy for varicose veins
- Tranexamic acid may reduce bleeding after cesarean delivery, but with a risk of adverse effects
- Topical application of tranexamic acid for the reduction of bleeding
- Vena caval filters for the prevention of pulmonary embolism
- Thromboprophylaxis for trauma patients
- Vena caval filters for the prevention of pulmonary embolism
- Rutosides for treatment of post-thrombotic syndrome: Cochrane systematic review
- Angioplasty or stenting for deep venous thrombosis
- Venous thromboembolism prophylaxis for women at risk during pregnancy and the early postnatal period
- Venous insufficiency of the lower limbs
- Heparin for the prevention of venous thromboembolism in acutely ill medical patients (excluding stroke and myocardial infarction): Cochrane systematic review
- Leg oedema
- Combined intermittent pneumatic leg compression and pharmacological prophylaxis for prevention of venous thromboembolism
- Aspirin no different than rivaroxaban for prevention of VTE after TKA or THA
- Simple risk score predicts severity of COPD exacerbations
- Simple risk model predicts risk of VTE after surgery
- Overweight in pregnancy
- Once versus twice daily low molecular weight heparin for the initial treatment of venous thromboembolism
- Prolonged fever in the adult
- Antithrombotic agents in primary health care
- Endovenous ablation therapy (laser or radiofrequency) or foam sclerotherapy versus conventional surgical repair for short saphenous varicose veins
- Treatment for femoral pseudoaneurysms
- Secondary prevention of recurrent venous thromboembolism after initial oral anticoagulation therapy in patients with unprovoked venous thromboembolism
- Compression therapy for prevention of post‐thrombotic syndrome
- Prophylactic anticoagulants for non‐hospitalised people with COVID‐19
- ACCP 2016: updated guidelines for VTE
- Risk prediction model predicts VTE recurrence after initial thrombotic event
- Reduced-dose apixaban noninferior to full dose for cancer-associated VTE after 6 months, with less bleeding
- Routine CT scans for occult malignancy not useful in patients with unprovoked VTE
- Interventions for preventing venous thromboembolism in adults undergoing knee arthroscopy
- Antithrombotic treatment after stroke due to intracerebral haemorrhage
- Statins for the primary prevention of venous thromboembolism
- Statins for primary prevention of venous thromboembolism
- Tranexamic acid for reducing mortality in emergency and urgent surgery
- Total knee replacement more effective for pain and function than nonsurgical treatment
- Different unfractionated heparin doses for preventing arterial thrombosis in children undergoing cardiac catheterization
- COVID-19 and other coronavirus infections
- Pentasaccharides for the prevention of venous thromboembolism: Cochrane systematic review
- Vascular closure devices for femoral arterial puncture site haemostasis
- Edoxaban as effective as LMWH for treatment of cancer-associated VTE
- SR: poor-quality data suggests stem cell joint injections are safe, but of unclear benefit
- Tinzaparin no better than warfarin in preventing recurrent VTE in adults with cancer
- Anticoagulants for people hospitalised with COVID‐19
- Preoperative education for hip or knee replacement: Cochrane systematic review
- Anticoagulants for acute ischaemic stroke
- Compression therapy for treating post‐thrombotic syndrome
- Different types of intermittent pneumatic compression devices for preventing venous thromboembolism in patients after total hip replacement: Cochrane systematic review
- Fixed-dose, subcutaneous, unfractionated heparin effective for VTE
- Continuous passive motion for preventing venous thromboembolism after total knee arthroplasty: Cochrane systematic review
- Low‐molecular‐weight heparins or heparinoids versus standard unfractionated heparin for acute ischaemic stroke
- Standard‐ versus extended‐duration anticoagulation for primary venous thromboembolism prophylaxis in acutely ill medical patients
- Peripherally inserted central catheter design and material for reducing catheter failure and complications
- Low molecular weight heparin for prevention of venous thromboembolism in patients with lower‐limb immobilization
- YEARS clinical decision tool decreases CT angiography in patients with suspected PE
- YEARS algorithm helpful for evaluating suspected PE in pregnant women
- Extended anticoagulation may be helpul for patients with unprovoked VTE or PE
- Femoral lines not associated with increased risk of bloodstream infections
- Edoxaban noninferior to warfarin for venous thromboembolism anticoagulation
- Transarterial (chemo)embolisation versus no intervention or placebo for liver metastases
- Postoperative tamoxifen for ductal carcinoma in situ
- Risk‐reducing medications for primary breast cancer: a network meta‐analysis
- Subcutaneous unfractionated heparin for the initial treatment of venous thromboembolism
- Pulmonary embolism rule-out criteria reduces the need for CT pulmonary angiography in low-risk patients (PERC)
- Apixaban is noninferior to dalteparin for venous thromboembolism associated with cancer
- Prevalence of pulmonary embolism is 5.9% in patients with COPD who are hospitalized with acute respiratory symptoms
- Lenalidomide effective for relapsed multiple myeloma
- Small benefit to extended treatment with apixaban in selected patients with VTE
- Perioperative bridging anticoagulation unhelpful for invasive procedures
- Positioning and spinal bracing for pain relief in metastatic spinal cord compression in adults
- Pharmacological interventions for the prevention of bleeding in people undergoing elective hip or knee surgery: a systematic review and network meta‐analysis
- Adder (Vipera berus) bite